Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

NCT07057778 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

NCT05846529 ·Status: UNKNOWN

A Multicenter Randomized Open-label Study of Chidamide Plus HD-DEX Versus HD-DEX in ITP

NCT05411874 ·Status: UNKNOWN ·Phase: PHASE2

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

NCT04949009 ·Status: UNKNOWN

Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00540423 ·Status: COMPLETED ·Phase: PHASE3

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.

NCT01101295 ·Status: UNKNOWN

Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient

NCT03222843 ·Status: COMPLETED ·Phase: PHASE3

A Study of Orelabrutinib in Patients With ITP

NCT05124028 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy and Safety of Iguratimod in the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

NCT05302024 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia

NCT01727232 ·Status: COMPLETED

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

NCT03951623 ·Status: COMPLETED ·Phase: PHASE1

High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

NCT05943691 ·Status: UNKNOWN ·Phase: PHASE2

Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

NCT07297563 ·Status: RECRUITING ·Phase: PHASE2

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

NCT02338414 ·Status: UNKNOWN ·Phase: PHASE2

Phase 2, Parallel Group, Rollover Study of AKR-501 in Patients With ChronicITP Who Completed 28 Days of Study Treatment in Protocol 501-CL-003

NCT00625443 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag Phase III Study In Chinese Chronic ITP Patients

NCT01762761 ·Status: COMPLETED ·Phase: PHASE3

Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

NCT04737850 ·Status: COMPLETED ·Phase: PHASE3

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

NCT01520909 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial of Chidamide in the Management of Refractory ITP

NCT03838354 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

NCT05263193 ·Status: COMPLETED

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

NCT04113915 ·Status: UNKNOWN

Herombopag + rhTPO in Severe Immune Thrombocytopenia

NCT05328804 ·Status: UNKNOWN ·Phase: PHASE3

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

NCT06199089 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

NCT04070599 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

NCT01013181 ·Status: COMPLETED